Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

Overview
Date Founded

2013

Headquarters

399 Thornall Street, 1st Floor, Edison, NJ, 08837, USA

Type of Company

Public

Employees (Worldwide)

12

Industries

Pharmaceuticals
Biotechnology

Company Description

Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Website

http://www.hepionpharma.com

Contact Data
Trying to get in touch with decision makers at Hepion Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
GlobeNewswire
December 23, 2020
H2 2020 Hepatitis B Pipeline Review - Therapeutics Development, Drug Profiles and Product Development Milestones
Nasdaq
December 11, 2020
Hepion Pharmaceuticals (HEPA) Jumps: Stock Rises 9%
ENP Newswire
December 11, 2020
-Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH
Nasdaq
December 9, 2020
Are Options Traders Betting on a Big Move in Hepion (HEPA) Stock?
ENP Newswire
November 25, 2020
-Hepion Pharmaceuticals Prices Public Offering

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Robert Foster

President, Chief Executive Officer & Director

John Cavan

Chief Financial & Accounting Officer

Daren Ure

Chief Scientific Officer

Daniel Trepanier

Senior Vice President, Drug Development

Patrick Mayo

Senior Vice President, Clinical Pharmacology

Rusty Cloud

Controller

Sharen Pyatetskaya

Director of Investor Relations

Jill Greytok

Associate Director

Siwei Nie

Associate Director II

Deborah Vatani

Manager of Data Content

Board of Directors
Gary S. Jacob

Chief Executive Officer & Director at OKYO Pharma Ltd.

John Patrick Brancaccio

Chief Financial Officer at Orchestra Medical Ventures LLC

Arnold Lippa

Founder at T. Morgen Capital LLC

Thomas H. Adams

Executive Director & Head-Drug Development at Tiziana Life Sciences Plc

Robert Foster

President, Chief Executive Officer & Director at Hepion Pharmaceuticals, Inc.

Peter L. J. Wijngaard

Chief Development Officer at The Medicines Co.

Timothy Block

Co-Founder at Baruch S. Blumberg Institute

Trending People
Federal Trade Commission
Biden adds Big Tech critic Tim Wu to his economic staff - Nasdaq
US House of Representatives
U.S. FDA looks to reduce toxic elements in baby food, boost inspections - Nasdaq
Arizona State University
Intelligent.com Announces Best Master's in Engineering Degree Programs for 2021;... - PR Newswire
Chevron Corp.
Chevron Is Admin. Law’s “Lord Voldemort” Say Tenth Cir. En Banc Dissenters in Bu... - GlobeNewswire
Texas A&M University
Intelligent.com Announces Best Master's in Engineering Degree Programs for 2021;... - PR Newswire
Trending Organizations
Federal Trade Commission
Biden adds Big Tech critic Tim Wu to his economic staff - Nasdaq
US House of Representatives
U.S. FDA looks to reduce toxic elements in baby food, boost inspections - Nasdaq
Arizona State University
Intelligent.com Announces Best Master's in Engineering Degree Programs for 2021;... - PR Newswire
Chevron Corp.
Chevron Is Admin. Law’s “Lord Voldemort” Say Tenth Cir. En Banc Dissenters in Bu... - GlobeNewswire
Texas A&M University
Intelligent.com Announces Best Master's in Engineering Degree Programs for 2021;... - PR Newswire
Paths to Hepion Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Hepion Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden
Sabby Capital LLC

Sabby Capital focuses on investments in the healthcare sector.

Details Hidden
Empery Asset Management LP

Empery Asset Management manages an event-driven, special situations fund that invests in small- to mid-sized growth companies. They make direct investments in US publicly-traded companies without respect to industry, although some of the companies are based in China.

Details Hidden
AIGH Capital Management LLC

Founded in 2011, AIGH Capital Management LLC is an investment advisor located in Baltimore, Maryland.

Recent Transactions
Details Hidden

Hepion Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Hepion Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Hepion Pharmaceuticals, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
John Patrick Brancaccio

Details Hidden
John Cavan

Details Hidden
Gary S. Jacob

Transaction Advisors
Auditor
BDO USA LLP

Advised onHepion Pharmaceuticals, Inc. issued USD Common Stock

Escrow Agent
Philadelphia Stock Transfer, Inc.

Advised onHepion Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor
Cooley LLP

Advised onHepion Pharmaceuticals, Inc. issued USD Common Stock and Warrants

Legal Advisor
Jeffrey J. Fessler

Advised onHepion Pharmaceuticals, Inc. issued USD Common Stock

Head of Investment Banking
Eric Lord

Advised onHepion Pharmaceuticals, Inc. issued USD Common Stock

Executive Director
Hugh Regan

Advised onHepion Pharmaceuticals, Inc. issued USD Common Stock
Advisors & Consultants
Consultant
John Sullivan-Bolyai

Former Director-Infectious Disease Clinical Research at Merck & Co., Inc.

Advisor
Nathaniel Katz

Founder at Analgesic Solutions

Publicist
Joshua Drumm

Senior Vice President, Investors Relations at Tiberend Strategic Advisors, Inc.
Key Stats and Financials As of 2019
Market Capitalization
$70.5M
Total Enterprise Value
$-447K
Earnings Per Share
$-5.95
Five Year Compounded Annual Growth Rate Of Revenue
0%
Three Year Compounded Annual Growth Rate Of Revenue
0%
Debt TEV
-1.81x
TEVNet Income
0.07x
Total Equity
$16.2M
Total Debt
$807K
EBITDA
$-7.74M
Net Profit
$-6.72M
Revenue
$0
Non-Profit Donations & Grants
$10K +
2017
Hepatitis B Foundation

Suppliers
Aurinia Pharmaceuticals, Inc. Hospitals & Patient Services | Victoria, Canada

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Biomodels LLC Biotechnology | Boston, MA

Biomodels LLC is a private company headquartered in Boston, MA. The firm engages in research and development of drugs.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hepion Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hepion Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Hepion Pharmaceuticals, Inc..